Understanding Parkinson's Treatment: How much does Vyalev cost?
•
4 min read
The estimated annual cost for Vyalev (foscarbidopa-foslevodopa) treatment ranges from approximately $62,023 to a wholesale acquisition cost of $119,000 per patient [1.2.1, 1.2.3]. This guide explores the various factors that influence the final price of this advanced Parkinson's disease therapy.
